PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2019
CASE
Daiichi-Sankyo UK ⭐ Case of the Week

Daiichi-Sankyo: draft corporate webpage accidentally went live and promoted POMs to the public (breach of undertaking)

A draft β€œfooter content” webpage became searchable on Daiichi-Sankyo’s UK site and promoted olmesartan, prasugrel and edoxaban to the public without PI…

2020
CASE
AUTH/3355/5/20 Britannia Pharmaceuticals

Britannia Pharmaceuticals UK: HCP prep-time payments, missing contracts and weak oversight of investigator-led trials (AUTH/3355/5/20)

Britannia was found in breach for paying unwarranted HCP preparation time (not FMV), making payments without fully executed contracts, and failing to…

2019
CASE
Otsuka

Otsuka Europe & Otsuka UK: Abilify Maintena prescribing information omitted monthly dosing frequency (breach of undertaking)

Otsuka Europe and Otsuka UK voluntarily admitted Abilify Maintena prescribing information omitted the word β€œmonthly” for IM maintenance dosing. The error persisted…

2021
CASE
AUTH/3550/7/21 Lundbeck

Lundbeck: Vyepti promoted pre-authorisation at Migraine Trust virtual symposium (AUTH/3550/7/21)

Lundbeck was found in breach after Vyepti (eptinezumab) was promoted before UK marketing authorisation at a Migraine Trust virtual symposium and via…

2021
CASE
AUTH/3576/11/21 Novo Nordisk

Novo Nordisk webinar invite: sponsorship disclosure not prominent at the outset (AUTH/3576/11/21)

A webinar invite sent via an independent organisation looked like the organisation’s own event. PMCPA found Novo Nordisk’s β€œorganised and fully funded”…

2022
CASE
AUTH/3621/3/22 Chiesi ⭐ Case of the Week

Chiesi breached the ABPI Code after a third-party event email implied sponsorship of a prize draw tied to attending its promotional session (AUTH/3621/3/22)

A MIMS Live event reminder offered a prize draw requiring attendance across all days, including Chiesi’s promotional session. The email didn’t clearly…

2022
CASE
AUTH/3604/1/22 Novo Nordisk

Novo Nordisk: LinkedIn post by third-party contractor deemed promotional and uncertified (AUTH/3604/1/22)

A UK-based contractor posted about oral semaglutide and linked a media article on LinkedIn. The Panel said the post was promotional and…

2022
CASE
AUTH/3627/4/22 Daiichi-Sankyo UK

Daiichi Sankyo breached the ABPI Code over Lixiana patient booklets that omitted key bleeding warning signs (AUTH/3627/4/22)

Two Lixiana patient booklets were ruled misleading for omitting PIL-listed signs of excessive bleeding and implying they contained all relevant safety info.…

2022
CASE
AUTH/3667/6/22 Roche Products

Roche: Mobile vs desktop webpage certification and alleged off-licence promotion (Kadcyla/Perjeta) – No breach (AUTH/3667/6/22)

Health professional alleged Roche needed separate certification for mobile webpage and that a meeting title implied broader HER2+ eBC indications for Kadcyla/Perjeta.…

2022
CASE
AUTH/3678/8/22 AstraZeneca

AstraZeneca breached Code over Symbicort MART messaging and missing PI reference in MIMS ad (AUTH/3678/8/22)

MIMS print ad implied all Symbicort strengths could be used for MART, despite 400/12 being maintenance-only, and failed to reference where PI…

2022
CASE
AUTH/3696/10/22 SOBI ⭐ Case of the Week

Sobi sponsored Guardian haemophilia article: no breach (AUTH/3696/10/22)

Anonymous complaint alleged a Guardian-sponsored corporate article was disguised promotion and misleading. PMCPA Panel ruled no breach of Clauses 3.6, 5.1, 6.1,…

2022
CASE
AUTH/3714/11/22 GlaxoSmithKline

AUTH/3714/11/22: GlaxoSmithKline – Trelegy website claim β€œA simple choice… easy to use and quick to teach” (No breach)

GSK’s HCP website described Trelegy Ellipta as β€œA simple choice. One inhaler, easy to use and quick to teach”. A health professional…

2023
CASE
AUTH/3721/1/23 Pfizer

Pfizer UK tweets linking to Pulse Today sponsored article: audience not stated and governance concerns (AUTH/3721/1/23)

Pfizer UK posted three public tweets linking to a Pulse Today sponsored article. Panel found the article not promotional and no POM…

2023
CASE
AUTH/3726/1/23 UCB

UCB: Senior UK employee β€˜liked’ LinkedIn post about Fintepla in Lennox-Gastaut Syndrome (AUTH/3726/1/23)

A Germany-based employee posted β€œHope for patients with Lennox-Gastaut Syndrome!” linking to a US press release about Fintepla. A senior UK employee…

2023
CASE
AUTH/3749/3/23 AGB-Pharma

AGB-Pharma: Adaflex promotional webpage accessible to the public via Google indexing (AUTH/3749/3/23)

AGB’s Adaflex branded webpage (intended for HCPs) became publicly accessible via a Google-indexed direct link, leading to breaches for website access controls…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training